Page last updated: 2024-10-27

gemfibrozil and alpha 1-Antitrypsin Deficiency

gemfibrozil has been researched along with alpha 1-Antitrypsin Deficiency in 1 studies

alpha 1-Antitrypsin Deficiency: Deficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN that manifests primarily as PULMONARY EMPHYSEMA and LIVER CIRRHOSIS.

Research Excerpts

ExcerptRelevanceReference
"Disease progression is associated with variation in AAT, and low AAT levels promote atherogenesis."2.71Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene. ( Flavell, DM; Frick, MH; Humphries, SE; Jackson, R; Kesäniemi, YA; Martin, S; Nagl, S; Nieminen, MS; Pasternack, A; Steiner, G; Syvänne, M; Talmud, PJ; Taskinen, MR; Whitehouse, DB, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Talmud, PJ1
Martin, S1
Steiner, G1
Flavell, DM1
Whitehouse, DB1
Nagl, S1
Jackson, R1
Taskinen, MR1
Frick, MH1
Nieminen, MS1
Kesäniemi, YA1
Pasternack, A1
Humphries, SE1
Syvänne, M1

Trials

1 trial available for gemfibrozil and alpha 1-Antitrypsin Deficiency

ArticleYear
Progression of atherosclerosis is associated with variation in the alpha1-antitrypsin gene.
    Arteriosclerosis, thrombosis, and vascular biology, 2003, Apr-01, Volume: 23, Issue:4

    Topics: 3' Untranslated Regions; Aged; Alleles; alpha 1-Antitrypsin; alpha 1-Antitrypsin Deficiency; Amino A

2003